Follow The Filings

ANTX An2 Therapeutics Inc.

Health Care, filed as AN2 THERAPEUTICS INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ANTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ANTX insider trades
  • $12K bought by 1 insider
  • None no sales outside a trading plan
  • $317K sold by 1 insider under 10b5-1 plans
  1. Robin Shane Readnour Director
    Planned sale
    $6,675 1,108 shares at $6.02 0.2% of stake
    Traded Sep 9 Filed Sep 11
    ↗
  2. Robin Shane Readnour Director
    Planned sale
    $97K 16,119 shares at $6.04 2.5% of stake
    Traded Sep 3–8 Filed Sep 8
    ↗
  3. Margaret M FitzPatrick Director
    Buy
    $12K 2,098 shares at $5.53 +24% to stake
    Traded Sep 1 Filed Sep 2
    ↗
  4. Robin Shane Readnour Director
    Planned sale
    $213K 35,402 shares at $6.01 5.3% of stake
    Traded Aug 17 Filed Aug 19
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants, 14 sales to cover taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
424B5 Filing Doc
424B3 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$64.73M -$51.32M -$35.17M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $110.51M $86.26M $59.94M
Total non-current assets * $28.24M $5.82M $2.01M
Total assets $138.74M $92.09M $61.95M
Total current liabilities $14.04M — $8.72M
Total non-current liabilities * $0.00 — $170,000
Total equity $124.7M $81.85M $53.06M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.29M -$49.26M -$29.83M
Cash from investing -$43.28M $54.59M $28.31M
Cash from financing $84.99M $0.372M $0.113M
Net change in cash -$11.57M $5.7M -$1.41M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf